Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 25 Breast Neoplasms 14 Neoplasms 12 Myelodysplastic Syndromes 12 Prostatic Neoplasms 10 Multiple Myeloma 8 Lung Neoplasms 7 Stomach Neoplasms 6 Sarcoma 6 Ovarian Neoplasms 5 Leukemia, Myelomonocytic, Chronic 5 Recurrence 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumor 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Solid Tumor 3 Small Cell Lung Carcinoma 3 Pain 3 Mucositis 3 Lymphoma, T-Cell, Peripheral 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomatitis 2 Skin Neoplasms 2

Interventions

masitinib 3 Imatinib Mesylate 3 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Stem Cell Transplantation 1 Sodium Chloride 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Injections 1 Dasatinib 1 Cyclophosphamide 1 Busulfan 1 BNT162 Vaccine 1 AK002 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mastocytosis × Injections × Clear all

NCT01333293 2016-01-18

XOLMA

University of Zurich

Phase 2/3 Completed

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡